PDCD1 and melanoma: A recent study reveals that a melanoma patient with resistance to PD-1 blockade carries a loss-of-function mutation in the E3 ligase FBXW7.205 Consistently, Fbxw7 deletion or mutation in mouse tumors confers their resistance to anti-PD1 therapy.